Back to Results
First PageMeta Content
Medicine / Pharmaceutical industry / Drug discovery / Medical statistics / Nursing research / Food and Drug Administration / Clinical trial / Regulatory requirement / Translational medicine / Health / Pharmaceutical sciences / Pharmacology


Deloitte’s Path to 21st Century Cures — A Call to Action Introduction Our country has had a strong commitment to life sciences research and development (R&D) for new treatments and
Add to Reading List

Document Date: 2014-07-31 11:03:18


Open Document

File Size: 981,67 KB

Share Result on Facebook

Company

European Investment Bank / Deloitte LLP / Coleman / Accelerating Medicines Partnership / Patient-Powered Research Networks / Clinical Data Research Networks / Pearson / New England Journal / Datamonitor / Deloitte Consulting LLP / /

Continent

Asia / South America / /

Country

France / Japan / United Kingdom / India / Mexico / United States / /

Currency

USD / /

Facility

Blood Institute / Institute of Medicine / pipeline Source / University of Cambridge Working Paper / Centered Outcomes Research Institute / /

IndustryTerm

digital technology / health technology / technological infrastructure / lower healthcare costs / software developers / value chain / learning healthcare system / featuremexico-drugs-pharmaceutical-brazil-south-america/ / generic pharmaceuticals / interoperable research networks / social media / medical products / bank / technology infrastructure / social networking / early phase product / social networks / public accounting / widespread networks / research infrastructure / data volumes management / life sciences products / technology capacity / supplemental applications / healthcare / pharmaceutical / health information technology / healthcare sector / biopharmaceutical / healthcare practitioners / mobile technology / wireless technology hubs / wearable tech products / social network / implantable technology / /

MedicalCondition

rare diseases / relatively unknown diseases / specific chronic condition / chronic conditions / epidemic predicting / chronic disease / diseases / orphan diseases / disease / chronic diseases / /

MedicalTreatment

bypass / /

Organization

Strong government / University of Cambridge Working Paper / National Heart Lung and Blood Institute / European Commission / National Center for Advancing Translational Sciences / FDA / European Union / Prioritization and Review Committee / Tunis SR / National Institute of Health / Electronic Health Records and Centered Outcomes Research Institute / Institute of Medicine / National Council for Public-Private Partnerships / Tufts Center / federal government / European Medicines Agency / U.S. Food and Drug Administration / London School of Economics / /

Person

Rebecca Warburton / /

Position

Mobile technology linking physician / physician / review and research scientist / /

Product

rituxan / /

ProgrammingLanguage

C / J / /

PublishedMedium

New England Journal of Medicine / /

Region

Oceania / New England / /

Technology

digital health Digital technology / html / Mobile technology / human genome / mobile devices / leveraging health technology / health information technology / genomics / Smartphone / pdf / Data mining / Drug Development / /

URL

http /

SocialTag